Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior. - Wikidata - awgldk - TriplyDB

Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior.

Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior.

http://www.wikidata.org/entity/Q37621854

about

Preterm birth in Caucasians is associated with coagulation and inflammation pathway gene variants Protective and damaging effects of stress mediators: central role of the brain Neuroendocrinal, Neurodevelopmental, and Embryotoxic Effects of Recombinant Tissue Plasminogen Activator Treatment for Pregnant Women with Acute Ischemic Stroke Mechanisms of stress in the brain EphBs: an integral link between synaptic function and synaptopathies New approaches to antidepressant drug discovery: beyond monoamines Amygdala protein kinase C epsilon regulates corticotropin-releasing factor and anxiety-like behavior The serine protease plasmin cleaves the amino-terminal domain of the NR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptors Angst and the amygdala Stress-induced glucocorticoid signaling remodels neurovascular coupling through impairment of cerebrovascular inwardly rectifying K+ channel function Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease.Effect of brain-derived neurotrophic factor haploinsufficiency on stress-induced remodeling of hippocampal neurons.Stress, sex, and neural adaptation to a changing environment: mechanisms of neuronal remodeling.Dynamic plasticity: the role of glucocorticoids, brain-derived neurotrophic factor and other trophic factors.Neuronal nitric oxide contributes to neuroplasticity-associated protein expression through cGMP, protein kinase G, and extracellular signal-regulated kinase.The ever-changing brain: cellular and molecular mechanisms for the effects of stressful experiences.Stress Effects on Neuronal Structure: Hippocampus, Amygdala, and Prefrontal Cortex.Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators.Tissue plasminogen activator modulates the cellular and behavioral response to cocaine.Inflammation and thrombosis biomarkers and incident frailty in postmenopausal women Passenger mutations and aberrant gene expression in congenic tissue plasminogen activator-deficient mouse strains.Hippocampal regulation of aversive memories.Effects of Ethanol on Brain Extracellular Matrix: Implications for Alcohol Use Disorder.Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells.Matrix metalloproteinases contribute to neuronal dysfunction in animal models of drug dependence, Alzheimer's disease, and epilepsy.Neuropsin cleaves EphB2 in the amygdala to control anxiety.BDNF-TrkB signaling through Erk1/2 MAPK phosphorylation mediates the enhancement of fear memory induced by glucocorticoids.Regulation of neuronal plasticity and fear by a dynamic change in PAR1-G protein coupling in the amygdala Tuning synaptic transmission in the hippocampus by stress: the CRH system.Involvement of tissue plasminogen activator in stress responsivity during acute cocaine withdrawal in mice.Morphine Withdrawal Increases Brain-Derived Neurotrophic Factor Precursor.Localization of plasminogen in mouse hippocampus, cerebral cortex, and hypothalamus.Tissue plasminogen activator in central nervous system physiology and pathology.MARCKSL1 Regulates Spine Formation in the Amygdala and Controls the Hypothalamic-Pituitary-Adrenal Axis and Anxiety-Like Behaviors.Characterization of Tissue Plasminogen Activator Expression and Trafficking in the Adult Murine Brain

P2860

Q21092178-B2B34338-5CC3-4D73-815B-D5D1223A389B Q24635626-29085CF6-62DC-491E-9DCE-50E5FF12AE7D Q26768616-1523FD15-9322-4823-B44B-78581777A97F Q26781233-AD387F68-E268-4E7F-A146-48E62BA8D1D2 Q26863347-BF1FB790-4003-4D44-BA0E-6321188A1093 Q28293089-1C33B749-C7EE-45AB-9388-FAE5EE6D7164 Q28510780-7DBE4319-F833-4394-B728-C52DAFB9E79D Q28771352-0ACD4858-9B2E-4E0C-9CC2-6D9A3EA75489 Q30473413-01A78998-BAEE-4277-A9C6-ABFBC0A3334D Q30578856-B3AE41E8-D36F-4700-A5A1-63ADE0F2F6CD Q33829618-9980F217-7189-4075-99FA-61E61B61DA96 Q33925737-4DFCAC9C-7362-4F99-AFDE-A46E5408BD55 Q34137906-99C07489-E99E-4B0D-9706-42149BB1C365 Q34295880-6B80C644-7A66-4F5D-8601-2C094CB62F77 Q35033344-4A65E21E-8BC8-4917-871E-95CEC6195B74 Q35641897-77831B30-B9B2-4A8B-9E23-03F4117C25B8 Q36366738-AAB09881-2946-4029-8431-FDA50308BD00 Q36776088-9E583FD0-9D4E-4729-B282-B3434EAFF6A6 Q37100946-6C882C79-80BE-4BF4-8E15-5A9387495827 Q37369015-A2D8E98A-6538-4DB9-85A6-27B6015A4D02 Q37661804-ABDDA3C9-7904-47A8-B2AE-DBF6A6EBDAFF Q37872468-7003EFC6-7213-4B5C-828A-BA78E9567D5F Q38942800-35E2B129-B410-44C9-833E-1614E6606600 Q40142332-4E165DC2-E69B-4EB6-802A-6A7E41FF4DB2 Q40234087-29BE3FAF-38FF-472E-B025-32AC08967EF8 Q41962381-99F56A09-E95E-45D5-8F1F-3BAAA0899D6D Q42116233-A349A7A8-88F8-43F6-A59F-4F026A335EE5 Q42513639-E364C442-2EE3-4FE0-85E4-CEC95DDC1A49 Q42552734-EEE2216C-4C51-4332-8B88-AE5186C25E43 Q42880635-3DDB1335-A279-4162-90A5-ED447C7DA129 Q47992008-E03FAE7C-2E47-4F1B-B8CF-FA9EADC4BBC5 Q51025843-8745E692-C5EA-497E-A056-B21B49EA05C6 Q51992729-049B36BA-B852-407F-BDE4-E2F093E7D4B9 Q53425220-D05478FC-CDC5-4D40-A0A3-D7C05B7C8327 Q58799360-B5485D05-86BA-4425-8FC7-EA48180FBB7A

P2860

Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior.

http://www.wikidata.org/entity/Q37621854

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Tissue plasminogen activator p ...... ala and anxiety-like behavior.

@en

Tissue plasminogen activator p ...... ala and anxiety-like behavior.

@nl

type

label

Tissue plasminogen activator p ...... ala and anxiety-like behavior.

@en

Tissue plasminogen activator p ...... ala and anxiety-like behavior.

@nl

prefLabel

Tissue plasminogen activator p ...... ala and anxiety-like behavior.

@en

Tissue plasminogen activator p ...... ala and anxiety-like behavior.

@nl

P1433

Q37621854-77ECA34A-4CE2-48BC-A610-D1FBB1F351CB

P1476

Q37621854-731C9C23-E51A-41F1-A8F5-844619DE4624

P2093

Q37621854-360AF78F-0BB5-4A63-9A00-B7A4B88E2294

Q37621854-3F44EC3C-9AE4-4337-A9D9-EC2538143DDF

Q37621854-5DC190E6-8211-4B3E-8794-03F9867D8474

Q37621854-B92D52B5-BD38-49FD-BCBB-EE1D5274453D

Q37621854-BBDAD982-ABA2-48B7-A453-C0C99478044B

P2860

Q37621854-062C8B3D-DD71-43B0-89DB-505C39D8C3E4

Q37621854-0C607AD1-17AD-4521-A513-162A39C8ADB9

Q37621854-118BB574-AB31-434F-8DB6-1362948A869F

Q37621854-1536E564-C5EA-4C5D-9495-5F5E96B54A12

Q37621854-15A7796A-F3C4-4EC8-BD32-688347A3592F

Q37621854-1D54AA93-0F09-426A-8766-DFF4160D370F

Q37621854-22767C32-D514-46A1-A94E-989E03C4460B

Q37621854-2BC1D423-3332-4EC9-8E93-C778B25EFFB8

Q37621854-31397F3C-D911-4FD9-9DB9-62F0EB393317

Q37621854-3A76E16E-93D4-4913-9DB3-B4A2AEFD3B16

P304

Q37621854-85214CFB-F039-4CAA-A80C-9B6B786E5478

P31

Q37621854-492D62CB-613B-4FBE-964F-236AC7C5FC01

P356

Q37621854-18411592-D3EF-4074-A474-E120ACB6E44A

P407

Q37621854-AEC75FC5-B254-4D59-857C-3A3E2BE8832E

P433

Q37621854-1008A34F-8605-42B8-8D1D-5879C2A20545

P478

Q37621854-029E03D5-D815-4A9C-A34D-F2529BAC633D

P50

Q37621854-29D46BCB-6A5D-4482-8E5F-CD31429A04FF

P577

Q37621854-83AE988B-9EE9-4C4F-B760-81B23C174398

P5875

Q37621854-D02B61A8-4130-4FBF-B17E-96916FA8DFD3

P698

Q37621854-5B808D9D-10B7-4C6D-94F8-DF0212368292

P932

Q37621854-4AC7CE21-D50F-4B36-80B4-AA8724A24FD5

P356

PNAS.0407355101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Tissue plasminogen activator p ...... ala and anxiety-like behavior.

@en

P2093

Bruce S McEwen

http://www.w3.org/2001/XMLSchema#string

Constantine Pavlides

http://www.w3.org/2001/XMLSchema#string

Elzbieta Matys

http://www.w3.org/2001/XMLSchema#string

Robert Pawlak

http://www.w3.org/2001/XMLSchema#string

Sidney Strickland

http://www.w3.org/2001/XMLSchema#string

P2860

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin

The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling.

The plasminogen (fibrinolytic) system.

A role for corticotropin releasing factor and urocortin in behavioral responses to stressors.

Circuits and mechanisms governing hypothalamic responses to stress: a tale of two paradigms.

Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation.

Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice.

Expression of c-fos protein in brain: metabolic mapping at the cellular level.

Extracellular proteolysis in the adult murine brain

P304

16345-16350

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0407355101

http://www.w3.org/2001/XMLSchema#string

P407

P433

46

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8197580

http://www.w3.org/2001/XMLSchema#string

P698

15522965

http://www.w3.org/2001/XMLSchema#string

P932

528975

http://www.w3.org/2001/XMLSchema#string